Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
Author:
Publisher
Frontiers Media SA
Subject
Microbiology (medical),Microbiology
Reference33 articles.
1. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.;Ajose;AIDS,2012
2. Virological failure in patients with HIV1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden.;Amanda;Lancet HIV,2016
3. Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South Africa.;Brado;Sci. Rep.,2018
4. ART-A Consortium. HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.;Bronze;PLoS One,2012
5. HIV-1 drug resistance and third-line therapy outcomes in patients failing second-line therapy in Zimbabwe.;Chimbetete;Open Forum Infect. Dis.,2018
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Virological impact of HIV drug-resistance testing in children, adolescents, and adults failing first-line ART in Tanzania;Journal of Global Antimicrobial Resistance;2024-08
2. HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola;Scientific Reports;2024-07-10
3. Implications and considerations of V179D mutation in a patient with HIV treated with cabotegravir/rilpivirine: A case report and mini‑review of the literature;World Academy of Sciences Journal;2024-03-04
4. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13
5. Understanding Drug Resistance of Wild-Type and L38HL Insertion Mutant of HIV-1 C Protease to Saquinavir;Genes;2023-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3